One-year results of switching to aflibercept for persistent diabetic macular edema resistant to bevacizumab

PURPOSE: The aim of this study is to evaluate the functional and anatomical effects of switching from bevacizumab to aflibercept in patients with persistent diabetic macular edema (DME) resistant to bevacizumab. MATERIALS AND METHODS: Patients with DME refractory to bevacizumab (1.25 mg/0.05 mL) wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Abouhussein, Mahmoud Alaa, Gomaa, Amir Ramadan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493997/
https://www.ncbi.nlm.nih.gov/pubmed/34703742
http://dx.doi.org/10.4103/tjo.tjo_85_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493997/
https://www.ncbi.nlm.nih.gov/pubmed/34703742
http://dx.doi.org/10.4103/tjo.tjo_85_20

Ejemplares similares